{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T06:00:25Z","timestamp":1785477625857,"version":"3.56.0"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>Opioid receptor antagonists, particularly naltrexone and nalmefene, are among the best-supported pharmacotherapies for alcohol use disorder (AUD), yet their clinical efficacy remains modest and highly heterogeneous. The mechanisms through which transient opioid receptor blockade produces sustained therapeutic benefit remain incompletely understood. Classical explanations emphasize attenuation of alcohol reward and suppression of craving, whereas extinction-based models propose that therapeutic effects emerge when alcohol consumption occurs under opioid receptor blockade, leading to weakening of conditioned drinking behavior. Clinical findings from targeted or \u201cas-needed\u201d treatment paradigms are broadly consistent with this interpretation. However, available observations are not fully explained by extinction alone. Preclinical animal studies suggest that subsequent alcohol drinking may depend critically on the timing of antagonist administration relative to alcohol exposure, including effects observed when opioid antagonists are administered immediately after drinking. Such findings raise the possibility that post-reward memory processes, including interference with reward-memory consolidation or reconsolidation, may contribute to therapeutic effects. Alternative explanations, including conditioned taste aversion, must also be considered, although the broader human literature more strongly supports modulation of reward and craving than generalized aversion. This mini-review integrates preclinical, clinical, and contemporary memory-neuroscience perspectives on opioid antagonist treatment in AUD. Improved understanding of these timing-dependent mechanisms, and their potential translational relevance to humans, may help explain clinical heterogeneity and guide the development of more targeted pharmacotherapeutic strategies.<\/jats:p>","DOI":"10.3389\/fnins.2026.1898127","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T05:37:13Z","timestamp":1785476233000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Opioid antagonist treatment in alcohol use disorder: extinction, reward memory, and the possible importance of timing"],"prefix":"10.3389","volume":"20","author":[{"given":"Iiro P.","family":"J\u00e4\u00e4skel\u00e4inen","sequence":"first","affiliation":[{"name":"Brain and Mind Laboratory, Department of Neuroscience and Biomedical Engineering, Aalto University School of Science","place":["Espoo, Finland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/0024-3205(80)90257-X","article-title":"Alteration of ethanol self-administration by naltrexone","volume":"26","author":"Altshuler","year":"1980","journal-title":"Life Sci."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1080\/09687630600902477","article-title":"Alcohol in Europe\u2014public health perspective: report summary","volume":"13","author":"Anderson","year":"2006","journal-title":"Drugs Educ. Prev. Policy"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","article-title":"Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial","volume":"295","author":"Anton","year":"2006","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/s0899-9007(98)00192-0","article-title":"Taste aversion learning: a contemporary perspective","volume":"15","author":"Bernstein","year":"1999","journal-title":"Nutrition"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1369-1600.2012.00442.x.","article-title":"Association of \u03bc-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis","volume":"17","author":"Chamorro","year":"2012","journal-title":"Addict. Biol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/alcalc\/35.6.587","article-title":"A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse","volume":"35","author":"Chick","year":"2000","journal-title":"Alcohol Alcohol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3758\/BF03328366","article-title":"Learning with prolonged delay of reinforcement","volume":"5","author":"Garcia","year":"1966","journal-title":"Psychon. Sci."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1080\/00952990.2024.2350056","article-title":"Effectiveness of psychosocial interventions for alcohol use disorder: a systematic review and meta-analysis update","volume":"50","author":"Ghosh","year":"2024","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"999","DOI":"10.2174\/156802609789630956","article-title":"Endogenous opioids and addiction to alcohol and other drugs of abuse","volume":"9","author":"Gianoulakis","year":"2009","journal-title":"Curr. Top. Med. Chem."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.euroneuro.2013.02.006","article-title":"A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence","volume":"23","author":"Gual","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/00004714-200106000-00006","article-title":"Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial","volume":"21","author":"Hein\u00e4l\u00e4","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e216","DOI":"10.1016\/j.bja.2019.03.031","article-title":"The opioid agonist remifentanil increases subjective pleasure","volume":"122","author":"Heiskanen","year":"2019","journal-title":"Br. J. Anaesth."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s002130050169","article-title":"Endogenous opioid systems and alcohol addiction","volume":"129","author":"Herz","year":"1997","journal-title":"Psychopharmacology"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s12264-024-01294-z","article-title":"Memory reconsolidation updating in substance addiction: applications, mechanisms, and future prospects for clinical therapeutics","volume":"41","author":"Huang","year":"2025","journal-title":"Neurosci. Bull."},{"key":"ref15","volume-title":"Rottien Alkoholin Juominen ja T\u00e4m\u00e4n Sammuttaminen Naloksonilla Kahdessa Erilaisessa Ymp\u00e4rist\u00f6ss\u00e4 [Extinction of Alcohol Drinking by Rats in Two Different Environments by Naloxone]","author":"J\u00e4\u00e4skel\u00e4inen","year":"1993"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0741-8329(97)00104-3","article-title":"Effects of naltrexone and ethanol on auditory event-related brain potentials","volume":"15","author":"J\u00e4\u00e4skel\u00e4inen","year":"1998","journal-title":"Alcohol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/npp.2009.110","article-title":"Neurocircuitry of addiction","volume":"35","author":"Koob","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1001\/jama.2018.11406","article-title":"Diagnosis and pharmacotherapy of alcohol use disorder: a review","volume":"320","author":"Kranzler","year":"2018","journal-title":"JAMA"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/JCP.0b013e3181ac5213","article-title":"Targeted naltrexone for problem drinkers","volume":"29","author":"Kranzler","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1056\/NEJMoa011127","article-title":"Naltrexone in the treatment of alcohol dependence","volume":"345","author":"Krystal","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.tics.2017.04.006","article-title":"An update on memory reconsolidation updating","volume":"21","author":"Lee","year":"2017","journal-title":"Trends Cogn. Sci."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1360-0443.2012.04054.x","article-title":"Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?","volume":"108","author":"Maisel","year":"2013","journal-title":"Addiction"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.biopsych.2012.10.020","article-title":"Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene","volume":"73","author":"Mann","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.neuro.27.070203.144157","article-title":"The amygdala modulates the consolidation of memories of emotionally arousing experiences","volume":"27","author":"McGaugh","year":"2004","journal-title":"Annu. Rev. Neurosci."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1001\/jama.2023.19761","article-title":"Pharmacotherapy for alcohol use disorder: a systematic review and meta-analysis","volume":"330","author":"McPheeters","year":"2023","journal-title":"JAMA"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"8230","DOI":"10.1523\/JNEUROSCI.1723-08.2008","article-title":"Intra-amygdala and systemic antagonism of NMDA receptors prevent the reconsolidation of drug-associated memory and attenuate cue-induced cocaine seeking","volume":"28","author":"Milton","year":"2008","journal-title":"J. Neurosci."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1111\/j.1530-0277.1999.tb04361.x","article-title":"Naltrexone\u2019s effect on cue-elicited craving among alcoholics in treatment","volume":"25","author":"Monti","year":"2001","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/35021052","article-title":"Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval","volume":"406","author":"Nader","year":"2000","journal-title":"Nature"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1001\/archpsyc.1992.01820110045007","article-title":"Naltrexone and coping skills therapy for alcohol dependence: a controlled study","volume":"49","author":"O\u2019Malley","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1038\/sj.npp.1300219","article-title":"A functional polymorphism of the \u03bc-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients","volume":"28","author":"Oslin","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e1001924","DOI":"10.1111\/add.13974","article-title":"Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate","volume":"12","author":"Palpacuer","year":"2015","journal-title":"PLoS Med."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"E116","DOI":"10.1111\/j.1530-0277.2012.01916.x","article-title":"Subjective response to alcohol among alcohol-dependent individuals: effects of the mu-opioid receptor (OPRM1) gene and alcoholism severity","volume":"37","author":"Ray","year":"2012","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1016\/S0140-6736(09)60746-7","article-title":"Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders","volume":"373","author":"Rehm","year":"2009","journal-title":"Lancet"},{"key":"ref9002","doi-asserted-by":"publisher","first-page":"CD001867","DOI":"10.1002\/14651858.CD001867.pub3","article-title":"Opioid antagonists for alcohol dependence","volume":"12","author":"Rosner","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1176\/appi.ajp.20220335","article-title":"Targeted oral naltrexone for mild to moderate alcohol use disorder among sexual and gender minority men: a randomized trial","volume":"179","author":"Santos","year":"2022","journal-title":"Am. J. Psychiatry"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1111\/j.1530-0277.2001.tb02309.x","article-title":"Effect of naloxone on appetitive and consummatory phases of ethanol self-administration","volume":"25","author":"Sharpe","year":"2001","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1111\/j.1530-0277.2001.tb02164.x","article-title":"Effects of naltrexone and Ro 15-4513 on a multiple schedule of ethanol and tang self-administration","volume":"25","author":"Shelton","year":"2001","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3109\/07853899009147920","article-title":"Drugs to decrease alcohol drinking","volume":"22","author":"Sinclair","year":"1990","journal-title":"Ann. Med."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/alcalc\/36.1.2","article-title":"Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism","volume":"36","author":"Sinclair","year":"2001","journal-title":"Alcohol Alcohol."},{"key":"ref9001","article-title":"Continued efficacy after naloxone-induced suppression of alcohol drinking: dependence upon relative timing","author":"Sinclair","year":"1995","journal-title":"Alcoholism: Clinical and Experimental Research 19, 13A"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1176\/ajp.151.10.1463","article-title":"Naltrexone-induced alterations in human ethanol intoxication","volume":"151","author":"Swift","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1177\/0269881114527362","article-title":"Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: a 1-year, randomised controlled study","volume":"28","author":"van den Brink","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1001\/archpsyc.1992.01820110040006","article-title":"Naltrexone in the treatment of alcohol dependence","volume":"49","author":"Volpicelli","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s002130050689","article-title":"Naltrexone reduces ethanol- and sucrose-reinforced responding in rhesus monkeys","volume":"139","author":"Williams","year":"1998","journal-title":"Psychopharmacology"},{"key":"ref44","volume-title":"Global status Report on Alcohol and Health 2018","year":"2018"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1126\/science.1215070","article-title":"A memory retrieval-extinction procedure to prevent drug craving and relapse","volume":"336","author":"Xue","year":"2012","journal-title":"Science"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2026.1898127\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T05:37:15Z","timestamp":1785476235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2026.1898127\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":46,"alternative-id":["10.3389\/fnins.2026.1898127"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2026.1898127","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"article-number":"1898127"}}